MR

Maurice R. Greenberg

Description

Maurice R. Greenberg - Chairman & Managing Director @ Starr Companies

Investor Profile

Maurice R. Greenberg has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in Israel.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series C (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Maurice R. Greenberg frequently co-invest with?

TV
North America, California, United States, San Francisco
Co-Investments: 1
NDFOS
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

Which angels does Maurice R. Greenberg often collaborate with?

Shared Deals: 1

What are some of recent deals done by Maurice R. Greenberg?

NeoTX Therapeutics

Rehovot, HaMerkaz, Israel

NeoTX Therapeutics is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.

BiotechnologyHealth CareHealth DiagnosticsMedicalOncologyTherapeutics
Series CFeb 19, 2020
Amount Raised: $45,000,000